Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 17, 2021

SELL
$180.55 - $233.54 $871,153 - $1.13 Million
-4,825 Reduced 50.84%
4,666 $1.07 Million
Q3 2018

Nov 16, 2018

BUY
$85.86 - $107.31 $814,897 - $1.02 Million
9,491 New
9,491 $654,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Omni Star Financial Group, Inc. Portfolio

Follow Omni Star Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.